Heavy and light chain variable regions of monoclonal antibodies against NS3 protein of bovine viral diarrhea virus
By developing heavy and light chain variable regions of NS3 protein monoclonal antibodies with high affinity and detection sensitivity, the existing diagnostic detection methods are solved, and the enzyme-linked immunity and inability to achieve The application of colloidal gold immunoassay is suitable for popularization of farms.
Patent Information
- Application Number
- CN202211290124.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-10-21
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2042-10-21
AI Technical Summary
The existing diagnostic and detection methods for viral diarrhea viruses have problems such as complex operation, expensive equipment and insufficient sensitivity, especially in popular farm applications, which are difficult to effectively detect.
The heavy and light chain variable regions of NS3 protein monoclonal antibodies against bovine viral diarrhea virus were developed, with high affinity and detection sensitivity, and are used for the research and development of enzyme-linked immunoassays and colloidal gold immunoassays, providing more sensitive and Specific detection method.
It improves the detection sensitivity and specificity of the NS3 protein of bovine viral diarrhea virus, realizes the application in enzyme-linked immunity and colloidal gold immunoassay, simplifies the detection process, and reduces the cost, making it suitable for popularization in farms.
Smart Images

Figure CN115724957B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of bovine viral diarrhea virus, in particular to heavy chain and light chain variable regions of a monoclonal antibody against NS3 protein of bovine viral diarrhea virus. Background Art
[0002] Bovine viral diarrhea virus (BVDV) is a representative species of the Flaviviridae family and the Pestivirus genus, which can cause viral diarrhea in cattle. BVDV is divided into genotypes, biotypes and serotypes. Genotypes include BVDV-1 and BVDV-2, and biotypes include cytopathic type (cp) and non-cytopathic type (ncp). Cattle of all ages are susceptible to infection, and the disease can be transmitted through direct or indirect contact. For example, it can be transmitted to animals indirectly through urine, excrement, amniotic fluid and oral and nasal secretions of infected cattle.
[0003] BVDV includes 4 structural proteins (C / Erns / E1 / E2) and 8 non-structural proteins (Npro, P7, NS2, NS3, NS4A, NS4B, NS5A and NS5B). For structural proteins, C protein constitutes the BVDV capsid; E0, E1 and E2 are glycosylated proteins that constitute the BVDV envelope. For non-structural proteins, the presence of NS2-3 in the host cell is a non-cytopathic cytopathic strain, and the presence of NS3 alone is a cytopathic strain.
[0004] NS3 protein, also known as P80 protein, has 680 amino acid residues and a molecular weight of 80kDa. It is a multifunctional protein with three enzyme activities. NS3 protein is relatively conservative and exists in large quantities in cells infected with cytopathic BVDV. The main antigenic epitope regions are all present in the helicase region, which can stimulate infected animals to produce antibodies to the virus. It is a non-structural protein with immune advantages and good conservation. Therefore, it has important diagnostic value. In addition, P80 antigen and P80 antibody have also become important targets for the diagnosis and detection of bovine viral diarrhea.
[0005] Traditional diagnostic methods for bovine viral diarrhea include serological testing and molecular biological methods. Among them, the molecular biological method is represented by polymerase chain reaction (PCR), which diagnoses whether animals are infected by detecting viral nucleic acids. However, its operation is complicated, and the reagents and equipment are expensive, making it difficult to popularize and apply it in cattle farms. Commonly used serological tests include enzyme-linked immunosorbent assay kit method and colloidal gold detection method. The principle is to detect whether animals are infected with BVDV or produce corresponding antibodies through antigen-antibody specific reactions. It has the characteristics of low price, high sensitivity, simple operation, and good specificity. Summary of the invention
[0006] The purpose of the present invention is to provide a heavy chain and light chain variable region of a monoclonal antibody against the NS3 protein of bovine viral diarrhea virus, which has high affinity and detection sensitivity to the NS3 protein of bovine viral diarrhea virus, and lays a foundation for the further development of enzyme-linked immunosorbent assay and colloidal gold immunoassay.
[0007] To achieve the above object, the present invention provides a heavy chain and light chain variable region of an anti-bovine viral diarrhea virus NS3 protein monoclonal antibody, wherein the gene sequence of the Kappa chain of the anti-NS3 protein monoclonal antibody is shown in SEQ ID NO.5, and the amino acid sequence thereof is shown in SEQ ID NO.6;
[0008] The gene sequence of the heavy chain of the anti-NS3 protein monoclonal antibody is shown in SEQ ID NO.7, and its amino acid sequence is shown in SEQ ID NO.8.
[0009] Preferably, the complementary determining region sequences of the light chain variable region are CDR1, CDR2, and CDR3, and their amino acid sequences are shown in SEQ ID NO.9, SEQ ID NO.10, and SEQ ID NO.11, respectively.
[0010] Preferably, the complementary determining region sequences of the heavy chain variable region are CDR1, CDR2, and CDR3, and their amino acid sequences are shown in SEQ ID NO.12, SEQ ID NO.13, and SEQ ID NO.14, respectively.
[0011] A DNA molecule encodes the heavy chain and light chain variable regions of the anti-NS3 protein monoclonal antibody.
[0012] The invention discloses an application of the heavy chain and light chain variable regions of the monoclonal antibody against NS3 protein of bovine viral diarrhea virus in detecting NS3 protein of bovine viral diarrhea virus.
[0013] The invention discloses an application of the heavy chain and light chain variable regions of the monoclonal antibody against NS3 protein of bovine viral diarrhea virus in preparing a genetically engineered antibody or vaccine with NS3 as a target.
[0014] Therefore, the present invention uses the heavy chain and light chain variable regions of the above-mentioned anti-BVD virus NS3 protein monoclonal antibody, which has high affinity and detection sensitivity for detecting BVD virus NS3 protein, laying a foundation for the further development of enzyme-linked immunosorbent assay and colloidal gold immunoassay.
[0015] The technical solution of the present invention is further described in detail below through the accompanying drawings and embodiments. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1The expression and purification results of BVDV NS3 protein were verified by SDS-PAGE electrophoresis;
[0017] Figure 2 It is a homology comparison of the light chain gene sequences of the monoclonal antibody against NS3 protein;
[0018] Figure 3 It is a homology comparison of the heavy chain gene sequences of the monoclonal antibody against NS3 protein;
[0019] Figure 4 It is a homology comparison of amino acid sequences of light chains of monoclonal antibodies against NS3 protein;
[0020] Figure 5 It is a homology comparison of the heavy chain amino acid sequences of anti-NS3 protein monoclonal antibodies. DETAILED DESCRIPTION
[0021] The technical solution of the present invention is further described below through the accompanying drawings and embodiments.
[0022] All terms (including technical terms or scientific terms) used in the present disclosure have the same meanings as those understood by ordinary technicians in the field to which the present disclosure belongs, unless otherwise specifically defined. It should also be understood that terms defined in general dictionaries should be understood to have meanings consistent with their meanings in the context of the relevant technology, and should not be interpreted in an idealized or extremely formal sense, unless explicitly defined in this document.
[0023] Technologies, methods, and equipment known to ordinary technicians in the relevant field may not be discussed in detail, but where appropriate, the technologies, methods, and equipment should be considered as part of the specification.
[0024] The disclosed contents of the prior art documents cited in the present specification are incorporated into the present invention by reference in their entirety and are therefore part of the disclosure of the present invention.
[0025] Embodiment 1
[0026] Construction of hybridoma cell lines
[0027] 1. NS3 gene sequence protein expression
[0028] According to the NS3 gene sequence of bovine viral diarrhea virus published in NCBI (DQ323915.1), the gene sequence was submitted to Wuhan Jinkairui Biotechnology Co., Ltd. for gene synthesis, synthesized into the pcold-TF vector, and maintained with BL21 competent host bacteria for expression and purification. The purified protein was verified by SDS-PAGE electrophoresis, and the purity was about 85% (see Figure 1 The purified protein was dialyzed with 1× PBS and stored at -20°C for later use.
[0029] exist Figure 1 In the figure, M is the molecular weight of the protein standard and 1 is the purified target protein.
[0030] 2. Construction of a hybrid cell line that stably secretes monoclonal antibodies against NS3 protein of BVDV
[0031] Initial immunization: emulsify the NS3 protein of BVD virus with Freund's complete adjuvant (1:1) and inject subcutaneously into 4 6-week-old BALB / C mice (numbered 1#, 2#, 3#, and 4#), with an immunization dose of 50 μg / mouse; starting from the first immunization, boost immunization was performed every 2 weeks, for a total of 2 boost immunizations, with Freund's incomplete adjuvant replacing Freund's complete adjuvant, and the method and dose were the same as the first immunization; one week after the second boost immunization, blood was collected from the fundus vein to measure the titer, and when the titer reached 1:10000 or above (see Table 1), a shock immunization was performed, that is, 100 μg of the immunogenic solution was injected intraperitoneally, 0.2 mL, and spleen cells were taken and fused with myeloma cells three days later to screen positive wells. The positive wells were cloned by limiting dilution method to obtain and establish a hybridoma cell line that stably secretes monoclonal antibodies against the NS3 protein of BVD virus.
[0032] Table 1 Detection of serum titers in immunized mice
[0033]
[0034] Embodiment 2
[0035] Sensitivity, specificity and subtype identification of monoclonal antibodies against NS3 protein of bovine viral diarrhea virus
[0036] The sensitivity and specificity of the anti-NS3 protein monoclonal antibody were tested by indirect Elisa method, as shown in Table 2. The monoclonal antibody was diluted in series with NS3 protein at 1 μg / mL to verify the monoclonal sensitivity. The results showed that the minimum sensitivity of the strain could reach 10 ng / mL (measured in OD 450nm The value was 2.1 times greater than the negative control and was considered positive). The specificity was then verified by coating with 1 μg / mL of bovine viral diarrhea NS3 protein, bovine rhinotracheitis virus particles, and bovine foot-and-mouth disease virus particles. The results showed that the specificity was good and it did not react with other viruses, as shown in Table 3.
[0037] Table 2 Monoclonal antibody sensitivity verification
[0038]
[0039] Table 3 Monoclonal antibody specificity verification
[0040] Coating antigen <![CDATA[OD 450nm ]]> Bovine viral diarrhea NS3 protein 2.201 Bovine rhinotracheitis virus particles 0.134 Bovine foot-and-mouth disease virus particles 0.122 Blank control 0.098
[0041] The subclass of the monoclonal antibody against BVDV NS3 protein was detected using an IgG subclass detection kit (Sigma, USA). The results showed that the monoclonal antibody against BVDV NS3 protein was IgG1 (κ).
[0042] Embodiment 3
[0043] Cloning of the heavy and light chain variable regions of monoclonal antibodies against NS3 protein of bovine viral diarrhea virus
[0044] (1) Hybridoma cell culture and total RNA extraction
[0045] 1×10 hybridoma cells were cultured in RPMI 1640 complete medium at 37°C and 5% carbon dioxide. 7 Total RNA was extracted from cells using a total RNA extraction kit (purchased from Tiangen).
[0046] (2) Synthesis of the first strand of cDNA
[0047] cDNA was synthesized according to the instructions of Takara transcription kit (Japan).
[0048] (3) Amplification of target gene
[0049] The target gene was amplified using the following Lambda chain, Kappa chain, Heavy chain downstream primers and upstream universal primers.
[0050] Primer: F:AAGCAGTGGTATCAACGCAGA (SEQ ID NO.1)
[0051] Rκ:AACATTGATGTCTTTGGGGTAGAA (SEQ ID NO.2)
[0052] Rλ:AATCGTACACACCAGTGTGTGGG (SEQ ID NO.3)
[0053] RH:AGGGATCCAGAGTTCCAGGT (SEQ ID NO.4)
[0054] The specific operations are:
[0055] PCR was performed using the first strand of cDNA as a template, with a reaction system of 50 μL.
[0056] Touchdown PCR reaction system: template 3μL, dNTPs 1μL, primer (10uM) 2.5μL, 5×PCR buffer 10μL, ddH 2 O 30.5μL, Taq enzyme (5U / μL), 0.5μL water.
[0057] The touchdown PCR reaction conditions were as follows: 98°C for 30 s; 98°C for 15 s, 64°C-58°C for 30 s, decreasing by 0.5°C each time until 58°C, for 10 cycles; 72°C for 30 s; 98°C for 15 s, 56°C for 30 s, 72°C for 30 s, for 15 cycles; 72°C for 7 min.
[0058] (4) Cloning and screening of PCR amplification products
[0059] The PCR products were subjected to 1.5% agarose gel electrophoresis, and the antibody Kappa chain, Lambda chain and Heavy chain fragments were recovered using a PCR product recovery kit (Beijing Tiangen). The fragments were inserted into the pLB vector using a pLB zero background rapid cloning kit (Beijing Tiangen), transformed into DH5α competent cells (ampicillin resistance), and the recombinant positive clones were screened for sequencing.
[0060] The PCR products were subjected to 1.5% agarose gel electrophoresis, and the results showed that no bands were observed in the Lambda chain. The gene sequence of the Kappa chain was shown in SEQ ID NO.5, and its amino acid sequence was shown in SEQ ID NO.6; the gene sequence of the Heavy chain was shown in SEQ ID NO.7, and its amino acid sequence was shown in SEQ ID NO.8.
[0061] (5) Analysis of variable region gene sequence and amino acid sequence homology
[0062] Comparison analysis was performed in the NCBI database. The results showed that the monoclonal antibody light chain variable region gene had the highest homology with the mouse immunoglobulin Kappa chain variable region gene (Sequence ID: S77425.1), with a homology of 401 / 422 and a homology percentage of 95%. Figure 2 .
[0063] The monoclonal antibody heavy chain variable region gene has the highest homology with the mouse immunoglobulin heavy chain variable region gene (Sequence ID: KT596271.1), with a homology of 412 / 431 and a homology percentage of 96%. Figure 3 .
[0064] The amino acid sequence of the variable region of the light chain of the monoclonal antibody has the highest homology with mouse IgG1 (κ) (Sequence ID: BCA37475.1), with a homology of 126 / 141 and a homology percentage of 89%. Figure 4 .
[0065] The amino acid sequence of the variable region of the monoclonal antibody heavy chain has the highest homology with the mouse immunoglobulin heavy chain (Sequence ID: AMB66478.1), with a homology of 131 / 143 and a homology percentage of 94%. Figure 5 .
[0066] The results of homology analysis of the gene sequences and amino acid sequences encoding the light chain and heavy chain variable regions of the monoclonal antibody showed that no sequence identical to the present invention was found. This result is consistent with the identification of the anti-bovine viral diarrhea virus NS3 protein monoclonal antibody as IgG1 (κ) using an IgG subclass detection kit (Sigma, USA).
[0067] The CDR regions of the light chain variable region and heavy chain variable region sequences are as follows:
[0068] Antibody light chain CDR region:
[0069] CDR1: KASHSVSNVVA (SEQ ID NO.9)
[0070] CDR2: YASNRYT (SEQ ID NO.10)
[0071] CDR3: QQDYSSPLT (SEQ ID NO.11)
[0072] Antibody heavy chain CDR region:
[0073] CDR1: RYWMS (SEQ ID NO.12)
[0074] CDR2: EINPDSSTINYTPSLKD (SEQ ID NO.13)
[0075] CDR3: VEYGNYGTMDY (SEQ ID NO. 14).
[0076] Embodiment 4
[0077] Establishment of a sandwich ELISA assay using monoclonal antibodies against NS3 protein of bovine viral diarrhea virus
[0078] The purified monoclonal antibody against NS3 protein of bovine viral diarrhea virus was labeled with HRP and used as enzyme-labeled secondary antibody, with a working concentration of 1:5000. The goat anti-bovine viral diarrhea virus NS3 polyclonal antibody was coated, and the NS3 protein of bovine viral diarrhea virus was used as a sample for gradient dilution to verify the sensitivity of the ELISA method for the double antibody detection antigen sandwich method of bovine viral diarrhea virus NS3. The results showed that the minimum sensitivity of this method could reach 10 ng / mL (see Table 4). Subsequently, the NS3 protein of bovine viral diarrhea, bovine rhinotracheitis virus particles and bovine foot-and-mouth disease virus particles were used as samples, coated with 1 μg / mL for incubation, and its specificity was verified. The results showed that it had good specificity and did not react with other viruses (see Table 5).
[0079] Table 4 Sensitivity verification of ELISA for bovine viral diarrhea virus NS3 double antibody detection antigen sandwich method
[0080] Sample concentration <![CDATA[OD 450nm ]]> 1 μg / mL 1.831 100ng / mL 0.932 10 ng / mL 0.236 Negative control 0.094
[0081] Table 5 Specificity verification of ELISA for bovine viral diarrhea virus NS3 double antibody detection antigen sandwich method
[0082] sample <![CDATA[OD 450nm ]]> Bovine viral diarrhea NS3 protein 1.03 Bovine rhinotracheitis virus particles 0.118 Foot-and-mouth disease virus particles 0.101 Blank control 0.091
[0083] Embodiment 5
[0084] 20 positive and negative sera were screened to verify the conformity of the ELISA antigen detection kit prepared in Example 4 with the commercially available bovine viral diarrhea virus colloidal gold antigen detection test strip.
[0085] The ELISA antigen detection kit prepared in Example 4 is judged by the following criteria: 450nm Value ≥2.1 times the negative control OD 450nm Mean, judged as positive; OD of the sample 450nm Value <2.1 times the negative control OD 450nm Mean, judged as negative.
[0086] The results showed that the ELISA antigen detection kit prepared in Example 4 had a 100% conformity with the commercially available bovine viral diarrhea virus colloidal gold antigen detection test strip (see Table 6), indicating that the present invention can distinguish between positive and negative sera and can be used in BVDV antigen detection and BVDV infection purification procedures.
[0087] Table 6 Serum test results of ELISA antigen detection kit and colloidal gold antigen detection test strips
[0088]
[0089] Therefore, the present invention uses the heavy chain and light chain variable regions of the above-mentioned anti-BVD virus NS3 protein monoclonal antibody, which has high affinity and detection sensitivity for BVD virus NS3 protein, laying a foundation for the further development of enzyme-linked immunosorbent assay and colloidal gold immunoassay.
[0090] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that they can still modify or replace the technical solution of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solution to deviate from the spirit and scope of the technical solution of the present invention.
Claims
1. A monoclonal antibody against NS3 protein of bovine viral diarrhea virus, characterized in that: The monoclonal antibody comprises heavy chain and light chain variable regions. The gene sequence of the Kappa chain of the anti-NS3 protein monoclonal antibody is shown in SEQ ID NO.5, and its amino acid sequence is shown in SEQ ID NO.6; the gene sequence of the Heavy chain of the anti-NS3 protein monoclonal antibody is shown in SEQ ID NO.7, and its amino acid sequence is shown in SEQ ID NO.8; The complementary determining region sequences of the light chain variable region are CDR1, CDR2, and CDR3, and their amino acid sequences are shown in SEQ ID NO.9, SEQ ID NO.10, and SEQ ID NO.11, respectively; The complementary determining region sequences of the heavy chain variable region are CDR1, CDR2, and CDR3, and their amino acid sequences are shown in SEQ ID NO.12, SEQ ID NO.13, and SEQ ID NO.14, respectively.
2. A DNA molecule encoding the anti-NS3 protein monoclonal antibody according to claim 1.
3. Use of the anti-BVD virus NS3 protein monoclonal antibody as claimed in claim 1 in the preparation of a kit for detecting BVD virus NS3 protein.
4. Use of the monoclonal antibody against NS3 protein of bovine viral diarrhea virus as claimed in claim 1 in the preparation of antibodies targeting NS3.
Citation Information
Patent Citations
Specific monoclonal antibody cell strain for bovine viral diarrhea virus and applications of specific monoclonal antibody cell strain
CN105838682A
BVDV E<rns> protein, antibody and method for screening BVDV infected cattle
CN109136267A
BVDV high-specificity nano antibody as well as preparation method and application thereof
CN113512110A
Direct immunofluorescence reagent and detection kit for detecting bovine viral diarrhea virus type 2
CN115112884A
Detection of bovine viral diarrhea virus in tissue samples
US20030143573A1
